Abstract a-Thalassemia (a-thal) is considered as the most common inherited hemoglobin disorder worldwide. The present study describes the first observation of a combination of rare a-chain variants, and b-globin gene cluster deletion. A 21-year-old woman with thalassemia trait, marked microcytosis, mild anemia, and normal range of Hb F was referred to Amirkola genetic center in the North of Iran for routine molecular test of thalassemia in the context of carrier detection and prevention of thalassemia major birth. Nucleotide sequencing revealed a novel compound heterozygosity status for two non-deletional mutations on HBA2, Hb O Indonesia (a116(GH4)Glu ? Lys), and Hb Matsue-Oki (a75 (EF4) Asp ? Asn), together with heterozygosity for the sicilian (db) 0 -thal mutation. This finding highlights the necessity of deep molecular investigation of thalassemia in regions where thalassemia is abundant, and present highly heterogeneous population.
Introduction
2 a-like and 2 b-like globin chains (a 2 b 2 ) would make human hemoglobin (Hb) at all the development stages. Mutations in the globin genes may cause blood disorder, during which the production, stability, and functional properties of Hb tetramers are affected. Unlike beta globin, 2 a-globin genes, i.e., a1 and a2 (HBA1 and HBA2), regulate a-globin synthesis on each copy of chromosome 16 (16p13.3). a-Thalassemia (a-thal) is considered as the most common inherited hemoglobin disorder worldwide, which is caused by deletional or non-deletional mutations of one or both a-globin genes characterized by hypochromic microcytic anemia with marked phenotypic heterogeneity that ranges from asymptomatic to lethal in utero. Most a-thal mutations are associated with deletions of one or both a-globin genes unlike the domination of non-deletional mutations in b-thal [1] . However, compared to the deletional a-thal types, a more severely reduced achain synthesis may be resulted from the non-deletional athal. The -a 3.7 (rightward) deletion in a-thal appears as the most frequent a-globin gene mutation in Iran, and is mostly asymptomatic. -a 3.7 is an example of a ? thalassemia, in which some a-globin chains are produced. When both a genes on a single chromosome are inactive, the a AE thalassemia is designated, which can present a more severe phenotypic manifestation based on the deleted region size of a-globin gene cluster.
mRNA processing and translation, as well as a-globin stability of either a2-or a1-globin genes have been described to be influenced by many a-globin point mutations. Considering its higher level of expression, a2-globin gene is mostly involved by the mentioned mutations. Generally, an abnormal a-chain Hb may be resulted from point mutations caused by the variant a-globin. Some of these hemoglobin variants are asymptomatic in the heterozygous state or may lead to only borderline hematological abnormalities. The phenotype is more evident when the patients are homozygous for such a variant or compound heterozygous with another a-thalassemic defect [2] .
Here, we report the first observation of a combination of Hb O Indonesia (a116(GH4)Glu ? Lys), and a rare achain variant, Hb Matsue-Oki (a75 (EF4) Asp ? Asn), in a 21-year-old female from Northern Iran, who was also heterozygous for the sicilian (db) 0 -thal mutation with a normal range of Hb F. She presented thalassemia trait with a marked microcytosis and mild anemia that was referred to Amirkola genetic center, Babol, Iran, and the molecular basis of her anemia still remained unknown after applying a routine alpha globin gene mutation analysis.
Case Presentation
A non-consanguineous married couple from Mazandaran province in Northern Iran with a positive history of bthalassemia major in the husbands' family was referred to Amirkola genetic center in Babol, Mazandaran for molecular analysis. The direct and indirect analyzes of a and b-globin gene mutations were performed for the husband and no mutations were detected. His wife, a 21-yearold female, was also screened for common b-globin gene mutations using an in-house reverse dot-blot assay and no mutations were found. Regarding the hematologic indices (Table 1) , the presence of common deletional delta beta and a-globin gene mutations were also analyzed. The results revealed that the wife had sicilian (db) 0 -thal mutation although the Hb F level was in the normal range. On the other hand, the hematological indices of the mentioned case were lower than an explainable mutation ( 
Discussion
Both alpha and beta thalassemia are frequent in Northern provinces of Iran, which harbors a very heterogeneous population [3] . [5] in the UK screening program. The residue location is on the external surface of the corner between the G-and H-helices. This position is near the alb1 contact. The replacement of negatively charged glutamic acid by positively charged lysine at residue 116 is structurally significant and thus can potentially lead to a functional or assembly defect. The previous studies demonstrated that the Hb O mutation is associated with either the instability of a OIna -globin chain or less efficient assembly of the hemoglobin in vivo [6] , which is also observed as a consequence of Hb E mutation due to the changes in Glu26Lys amino acid in the b-globin chain. Hb O Indonesia was also found in combination with Sickle Hemoglobin (Hb S) in an Indian family, where the newborn infant was seen to have reduced Hb levels and need to be followed up. The baby's follow-up suggested no clinical problems [7] . The mentioned hemoglobin was also found in association with Hb D-Punjab, but the presence of abnormal hemoglobins was not associated with hemolytic disorders or obvious clinical symptoms. Carrying a heterozygous Hb O mutation was also observed to be involved in a milder phenotype of a homozygous b-thalassemia individual [8] .
We also found another transition at codon 75 (HBA2: c. 226G [ A) changing the protein residue aspartic acid to asparagine at position a 75(EF4) Asp ? Asn (GAC [ AAC) on the a2-globin gene that was previously reported as Hb Matsue-Oki. The aspartic acid residue is the 4th amino acid of the EF interhelical segment and is located in the external position of the Hb molecule. It is not involved in the heme or interchain contacts. The deletion of one of the aspartyl residues described in Hb Watts induces only a slight instability in vitro without any thalassemialike phenotypes. Hb Matsue-Oki (M-O) had been reported from a few Japanese and African ethnic origins and also in the Dutch thalassemia screening program [9, 10] . However, this is the first time it is being reported in Iran. Hb G-Philadelphia [alpha68(E17)Asn-[ Lys] related to alpha-thal-2 (-3.7 kb) was found to occur in a black family in association with Hb M-O. Their clinical and hematological conditions could be compared with a mild heterozygosity of a-thalassemia-2 as a simple Hb G-Philadelphia trait [9] , but carriers whose chromosomes showed to bear this hemoglobin variant were asymptomatic. Nevertheless, the co-inheritance of 2 rare a-chain variants and a delta beta-thalassemia mutation can be at the origin of the low hematological indices of the present mentioned case. Therefore, considering a region with such a heterogeneous population and high thalassemia prevalence, it is necessary to evaluate more precisely both common and rare point mutations as well as gene deletions through the molecular characterization of the a-and bglobin gene clusters even if the Hb F value is within the normal range. A quick and precise recognition of globin gene mutations can lead to an improved genetic counseling quality. The co-inheritance of a sicilian delta beta deletion and 2 rare a-chain variants reflects the complexity of diagnosing and prevention of thalassemia in heterogeneous populations and the necessity for a wider range of clinical, hematological, and molecular approaches to addressing this issue. In the present case, although prenatal diagnosis of the fetus was not necessary, but regarding the 50% risk of inheritance of db thalassemia from the mother, molecular analysis of this mutation in all siblings of this family is recommended. Also, those siblings carrier of db thalassemia have about 10% chance of marrying a beta thalassemia minor (regarding carrier prevalence in the population), and therefore being at risk of having an affected child. Moreover, molecular investigation of db thalassemia in couples with anemia in which the HbF level is not necessarily elevated is recommended regarding complex situations that may happen due to the interference of modifier genes such as alpha globin. Correspondingly, carrier couples with db thalassemia each or with db thalassemia and b thalassemia need to be offered prenatal diagnosis regarding the 25% risk of having a thalassemia major or intermedia child.
